Types segmentation classifies Workplace Drug Testing Service offerings by biological matrix and analytical methodology. Urine testing remains the dominant modality due to its low cost, established cutoff thresholds, and broad detection window, representing the bulk of laboratory volume. Saliva testing provides a shorter detection window and is favored for on‑site, rapid results, influencing markets where immediate decision‑making is critical. Hair testing extends detection to months, supporting forensic‑level investigations and high‑risk occupations, albeit at a higher per‑test price. Blood testing offers quantitative concentration data, essential for legal or medical adjudication, and therefore occupies a specialized niche. Sweat and breath analyses are emerging non‑invasive options that address privacy concerns and enable continuous monitoring in select sectors. Each type contributes distinct cost structures, turnaround times, and regulatory acceptance levels, shaping the overall market composition and informing providers’ portfolio strategies within the Workplace Drug Testing Service segmentation framework.